Reaction

Anaplastic Thyroid Cancer reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 121 reports · 2 co-occurring drugs

As of the last recalculation, Anaplastic Thyroid Cancer appears in 121 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is DABRAFENIB (PRR 648.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dabrafenib48648.9650.4
Trametinib44491.6492.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.